Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), sold 8,849 shares at $15.32 ($136K) on 2022-11-10, disclosed to the SEC on 2022-11-14.
Open-market sale of $136k ANTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.32 | 4,413 | $68K | 49.9% |
| 2 | $15.32 | 4,413 | $68K | 49.9% |
| 3 | $15.04 | 23 | $346 | 0.3% |
| Total | $15.32 avg | 8,849 | $136K | 100% |
| Filing → |
| ANTX | SELL | 2024-01-04 | $112K | — | Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-09 | $426K | — | Filing → |